Rajeev M. Shah's Net Worth

$2.25 Billion

Estimate Recalculated Feb 20, 2024 08:09PM EST

Who is Rajeev M. Shah?

Rajeev M. Shah has an estimated net worth of $2.25 Billion. This is based on reported shares across multiple companies, which include AN2 Therapeutics, Inc., RHYTHM PHARMACEUTICALS, INC., Vaxcyte, Inc., iTeos Therapeutics, Inc., Mineralys Therapeutics, Inc., Cytek Biosciences, Inc., PMV Pharmaceuticals, Inc., Nkarta, Inc., DICE Therapeutics, Inc., Icosavax, Inc., Tyra Biosciences, Inc., MIRAGEN THERAPEUTICS, INC., Inhibrx, Inc., RxSight, Inc., Phathom Pharmaceuticals, Inc., Dyne Therapeutics, Inc., TG THERAPEUTICS, INC., Eliem Therapeutics, Inc., KalVista Pharmaceuticals, Inc., Vor Biopharma Inc., Verastem, Inc., Janux Therapeutics, Inc., Aerovate Therapeutics, Inc., Forma Therapeutics Holdings, Inc., Therapeutics Acquisition Corp., Synthorx, Inc., Eidos Therapeutics, Inc., Acumen Pharmaceuticals, Inc., 89bio, Inc., Solid Biosciences Inc., Inozyme Pharma, Inc., Pandion Therapeutics, Inc., Iterum Therapeutics plc, Kala Pharmaceuticals, Inc., Orchard Therapeutics plc, Satsuma Pharmaceuticals, Inc., Akouos, Inc., Black Diamond Therapeutics, Inc., Cardiff Oncology, Inc., Werewolf Therapeutics, Inc., Enliven Therapeutics, Inc., Ra Pharmaceuticals, Inc., Wave Life Sciences Ltd., Fulcrum Therapeutics, Inc., scPharmaceuticals Inc., ARS Pharmaceuticals, Inc., PepGen Inc., and Acrivon Therapeutics, Inc..

SEC CIK

Rajeev M. Shah's CIK is 0001619841

Past Insider Trading and Trends

2022 was Rajeev M. Shah's most active year for acquiring shares with 89 total transactions. Rajeev M. Shah's most active month to acquire stocks was the month of May. 2021 was Rajeev M. Shah's most active year for disposing of shares, totalling 44 transactions. Rajeev M. Shah's most active month to dispose stocks was the month of May. 2020 saw Rajeev M. Shah paying a total of $380,510,856.12 for 50,220,677 shares, this is the most they've acquired in one year. In 2020 Rajeev M. Shah cashed out on 134,050,196 shares for a total of $1,603,221,525.90, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

AN2 Therapeutics, Inc. (ANTX) Snapshot price: $20.99

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+52.94%
1.78M
$9.00
$16,000,002.00
5.14M
Aug 18
Form 4
+0.03%
1.91K
$7.74
$14,330.32
7.55M
Aug 3 - Aug 4
Form 4
+0.62%
23.22K
$7.78
$180,674.69
3.77M
Jul 26 - Jul 27
Form 4
+0.01%
302
$7.99
$2,412.98
3.75M
Jun 21
Form 4
+2.22%
81.42K
$7.95
$647,401.86
3.75M
Jun 13 - Jun 14
Form 4
3.67M
$15.00
3.67M
Mar 29
Form 3
0
0
No matching records found

RHYTHM PHARMACEUTICALS, INC. (RYTM) Snapshot price: $47.91

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-5.19%
-238.54K
$29.47
-$7,029,652.62
4.36M
Dec 2 - Dec 3
Form 4
-2.50%
-131.58K
$22.06
-$2,902,517.12
5.14M
Jun 30 - Jul 2
Form 4
-2.77%
-150.32K
$23.05
-$3,465,614.60
5.27M
Jun 25 - Jun 29
No matching records found

Vaxcyte, Inc. (PCVX) Snapshot price: $74.01

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-5.05%
-266.26K
$50.78
-$13,521,592.46
5M
Oct 7 - Oct 8
Form 4
-3.94%
-221.33K
$49.81
-$11,245,562.88
5.39M
Sep 29 - Oct 1
Form 3
0
0
No matching records found

iTeos Therapeutics, Inc. (ITOS) Snapshot price: $10.52

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
Jun 9
Form 4
+13.93%
421.21K
$34.18
$14,396,855.26
3.45M
Apr 1
Form 4
4.42M
$19.00
4.42M
Jul 28
Form 3
0
0
No matching records found

Mineralys Therapeutics, Inc. (MLYS) Snapshot price: $12.28

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+127.55%
1.67M
$13.50
$22,578,858.00
2.98M
Feb 12
Form 4
3.18M
$16.00
3.18M
Feb 14
Form 4
0
0
Feb 9
Form 3
0
0
No matching records found